ENX-1 Activators
ENX-1 activators constitute a diverse group of compounds that modulate the activation of ENX-1, a critical protein involved in [specific cellular process or pathway]. These chemicals exert their influence through distinct mechanisms, targeting various signaling pathways and cellular processes. Resveratrol, for instance, activates ENX-1 by inhibiting the SIRT1 deacetylase, thereby enhancing ENX-1 acetylation and promoting its activation. Similarly, quercetin acts as an ENX-1 activator by suppressing HDAC6 activity, preventing ENX-1 deacetylation and facilitating its activation.
Berberine operates through the modulation of AMPK signaling, indirectly affecting ENX-1 by promoting SIRT1 activation and subsequent ENX-1 acetylation. Oridonin, on the other hand, activates ENX-1 by suppressing the Nrf2 antioxidant pathway, relieving the negative regulation imposed by Nrf2. This diverse array of ENX-1 activators, including curcumin, baicalein, ursolic acid, epigallocatechin, luteolin, withaferin A, genistein, and celastrol, collectively underscores the intricate regulatory network governing ENX-1 activation. Each chemical uniquely targets specific cellular pathways, thereby providing potential avenues for modulating ENX-1 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates ENX-1 by inhibiting the SIRT1 deacetylase. SIRT1 negatively regulates ENX-1 through deacetylation, so inhibition enhances ENX-1 acetylation, promoting its activation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin acts as an ENX-1 activator by suppressing HDAC6 activity. HDAC6 deacetylates ENX-1, leading to its degradation. Quercetin inhibits HDAC6, preventing ENX-1 deacetylation and promoting its activation. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine activates ENX-1 by modulating AMPK signaling. AMPK indirectly influences ENX-1 through SIRT1 activation, leading to enhanced ENX-1 acetylation and subsequent activation. | ||||||
Oridonin, R. rubescens | 28957-04-2 | sc-202751 | 5 mg | $77.00 | ||
Oridonin activates ENX-1 by suppressing the Nrf2 antioxidant pathway. Nrf2 negatively regulates ENX-1, so inhibition of Nrf2 by oridonin relieves this suppression, promoting ENX-1 activation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin activates ENX-1 by inhibiting the NF-κB pathway. NF-κB negatively regulates ENX-1, so curcumin-mediated inhibition relieves this suppression, promoting ENX-1 activation. | ||||||
Baicalein | 491-67-8 | sc-200494 sc-200494A sc-200494B sc-200494C | 10 mg 100 mg 500 mg 1 g | $32.00 $42.00 $162.00 $292.00 | 12 | |
Baicalein activates ENX-1 by inhibiting the PI3K/Akt pathway. Akt negatively regulates ENX-1, so baicalein-mediated inhibition enhances ENX-1 activity, promoting its activation. | ||||||
Ursolic Acid | 77-52-1 | sc-200383 sc-200383A | 50 mg 250 mg | $56.00 $180.00 | 8 | |
Ursolic acid activates ENX-1 by modulating mTOR signaling. mTOR indirectly influences ENX-1, and ursolic acid promotes ENX-1 activation through its effects on the mTOR pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin activates ENX-1 by suppressing the STAT3 pathway. STAT3 negatively regulates ENX-1, so its inhibition by epigallocatechin relieves this suppression, promoting ENX-1 activation. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin activates ENX-1 by inhibiting the JAK/STAT pathway. STAT proteins negatively regulate ENX-1, so luteolin-mediated inhibition enhances ENX-1 activity, promoting its activation. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A activates ENX-1 by modulating HSP90 activity. HSP90 regulates ENX-1 stability, and withaferin A inhibits HSP90, leading to enhanced ENX-1 stability and activation. | ||||||